Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > FDA taking a year for IBRX review

<< Previous

Bullboard Posts

Next >>

Post by N0taP00pon Nov 11, 2022 10:59am

258 Views

Post# 35091419

FDA taking a year for IBRX review

Doesn't Immunity Bio have BTD already? If their biologics application can take almost a year to get approved, why would Theralase's go any faster? I know there's no BCG involved and fewer treatments. But still, wondering. Health Canada is not even on the radar.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?